Mark Sheptoff Financial Planning, LLC Genmab A/S Transaction History
Mark Sheptoff Financial Planning, LLC
- $182 Million
- Q4 2024
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Genmab A/S stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 1,400 shares of GMAB stock, worth $27,664. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,400
Previous 1,400
-0.0%
Holding current value
$27,664
Previous $34,000
14.71%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
61.3MCall Options Held
159KPut Options Held
38K-
Alliancebernstein L.P. New York, NY14.9MShares$295 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$100 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$61.1 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$55.6 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$55.4 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...